Ticker
Reporting Basis
Period
From
To
Form Type
Report Format
Update Type

BIO-RAD LABS -A   FYE=12 (December)

Annual - Income Statement - Company Specific

Fiscal period2024202320222021202020192018201720162015
Period End Date12/31/202412/31/202312/31/202212/31/202112/31/202012/31/201912/31/201812/31/201712/31/201612/31/2015
Sales2,566.502,671.262,802.252,922.552,545.632,311.662,289.422,160.152,068.172,019.44
Total Revenues2,566.502,671.262,802.252,922.552,545.632,311.662,289.422,160.152,068.172,019.44
Cost of good sold1,187.601,244.321,234.921,281.881,107.801,054.661,066.26972.75930.09897.77
Gross Profit1,378.901,426.951,567.331,640.661,437.821,257.001,223.151,187.401,138.091,121.67
Goodwill amortization--------------------
Product research and development expense--247.43256.89271.66226.60202.71199.20250.30205.86192.97
Purchased in-process research and development expense295.90------------------
Selling, general and administrative expense814.00841.72827.83879.57800.27824.63834.78808.94816.72761.99
Impairment losses on goodwill and long-lived assets------------(292.51)(11.51)(62.31)--
Operating Income (loss)269.00337.80482.62489.43410.96229.66(103.34)116.6553.19166.71
Interest expense48.9049.4438.111.5521.8623.4223.9621.9121.9421.69
Change in fair market value of equity securities(2,656.80)(1,252.25)(5,193.55)4,926.254,495.832,030.99606.23------
Other (income) expense, net90.30106.4444.5726.7824.4926.0936.5912.2014.8511.08
Foreign exchange (gains) losses3.907.350.21(2.75)(1.77)(2.25)(2.86)(9.13)(4.54)(10.25)
Income before taxes----(4,704.27)5,438.154,907.642,261.08512.6697.8141.56145.85
Pre-Tax Income - International--------------------
Pre-Tax Income - U.S--------------------
Income from continuing operations before taxes(2,342.50)(850.10)----------------
Provision for income taxes(498.30)(212.78)(1,076.74)1,192.251,101.37502.41147.05(24.44)13.4432.75
Deferred tax expense--------------------
Deferred Tax--------------------
Current Tax : U.S--------------------
Current Tax : International28.5017.4024.1032.60------------
Deferred Tax : U.S--------------------
Deferred Tax : International(20.50)(15.20)(36.70)32.10------------
Current Tax : U.S. Federal81.0073.80112.8072.40------------
Current Tax : U.S. State14.0012.0020.109.20------------
Deferred Tax : U.S. Federal(571.60)(291.70)(1,121.30)981.30------------
Deferred Tax : U.S. State(34.70)(15.70)(83.60)68.90------------
Non-current tax expense5.006.607.90(4.30)------------
Minority interests in earnings of consolidated subsidiaries--------------------
Income from Continuing Operations--------------------
Discontinued operations : Gain on divestiture, net of tax benefits--------------------
Discontinued operations : Loss from discontinued operations--------------------
Total income from discontinued operations--------------------
Income before cumulative effect of change in accounting principle--------------------
Net income including noncontrolling interests(1,844.20)(637.32)(3,627.54)4,245.903,806.271,758.68365.61122.25--113.09
Less: Net income attributable to noncontrolling interests--------------------
Net Income (Loss) Available to Common Shareholders(1,844.20)(637.32)(3,627.54)4,245.903,806.271,758.68365.61122.2528.13113.09
Earnings Per Share (Basic) - Cont Ops--------------------
EPS (Basic) : Disc Ops--------------------
Net income per share (basic)(65.36)(21.82)(121.79)142.33127.8658.9312.254.120.963.87
Earnings Per Share (Diluted) - Cont Ops--------------------
Earnings Per Share (Diluted) - Disc Ops--------------------
Net income per share (diluted)(65.36)(21.82)(121.79)140.56126.2058.2712.104.070.953.85
Weighted Average Shares Outstsanding (Basic)28.2129.2129.7929.8329.7729.8429.8429.6629.4429.19
Weighted Average Shares Outstsanding (Diluted)28.2129.2129.7930.2130.1630.1830.2330.0329.6529.41